Skip to main content

Table 3 Summary of patients who died during the 5 year follow up period

From: Effect of Erythropoietin in patients with acute myocardial infarction: five-year results of the REVIVAL-3 trial

Patient # Group Cause of death
1 Placebo cardiogenic shock
2 Placebo cardiogenic shock
3 EPO lung embolism
4 Placebo sudden cardiac death
5 EPO septic shock, stroke
6 EPO cancer
7 Placebo after orthopedic surgery
8 EPO sudden cardiac death
9 EPO unknown
10 Placebo cancer
11 EPO sudden cardiac death
12 Placebo unknown
13 EPO unknown
14 EPO unknown
  1. Patient # 1–5 died 1–186 days after randomization. Patient # 7–14 died 187–1860 days after randomization